Announcements

Intimation about the outcome of the Board Meeting held on 09-02-2019 – Approval of unaudited financial results for the quarter / nine months ended 31-12-2018.

Intimation that Dr. A. Velumani, Chairman, Managing Director & CEO, would be participating at ‘10^th Eureka Conference- London’ organized by M/s. Motilal Oswal Financial Services Limited, at St James Court, A Taj Hotel, London on 11^th and 12^th February 2019, where representatives of various fund houses would be meeting him.

Intimation that Dr. A. Velumani, Chairman & Managing Director, would be participating at ‘10th Enterprising India Investors’ Conference organized by M/s. IIFL- Institutional Equities, at Hotel Trident BKC, Mumbai, on Wednesday, 13th February 2019, where representatives of various fund houses would be meeting him, from 02.00 P.M to 6.00 P.M.

Intimation that Mr. Sachin Salvi, General Manager- Finance would be participating at ‘Build India, New India’ Investor Conference organized by M/s. Antique Stock Broking Limited, at Hotel Sofitel BKC, Mumbai, on Tuesday, 12th February 2019, where representatives of various fund houses would be meeting him, from 10.00 A.M to 2.00 P.M.

Intimation about Board Meeting scheduled to be held on February 09, 2019 to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / nine months ended  31st December 2018 and to consider declaration of interim dividend, if any.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from January 29, 2019 to February 12, 2019. (both days inclusive).

Intimation that a team of Fund Managers and Research Analysts of Malabar Investments would be having a meeting with Dr. A. Velumani, Chairman, Managing Director & CEO, Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, Dr. Caesar Sengupta, Vice-President-Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Monday, December 17, 2018.

Intimation that Ms. Alka Katiyar, Research Associate- Pharma Institutional Equities of IndiaNivesh Securities Limited would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 11, 2018.

Intimation that Mr. Robert Harvey and Mr. Taizo Ishida, Portfolio Managers of Matthews Asia would be having a meeting with  Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde,Deputy  General Manager- Finance at Hotel Trident, BKC by 09.00 A.M. on Wednesday, December 05, 2018.

Intimation that Mr. Shrikant Akolkar, Senior Analyst- Pharma of IIFL Securities Limited would be having a meeting with Mr. Sachin Salvi,  General Manager-Finance, at our office by 11.00 A.M. on Tuesday, December 04, 2018.

Intimation that Ms. Charvi Pandey, Analyst of Fidelity International would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 10.00 A.M. on Tuesday, December 11, 2018 and she will also visit our CPL after meeting.

Intimation that Mr. Kalpesh Parekh, Vice President- Institutional Sales and Mr. Surajit Pal, Analyst of Prabhudas Lilladher Pvt. Ltd. would be having a meeting with Dr. Caesar Sengupta, Vice-President- Operations and Mr. Sachin Salvi, General Manager-Finance, at our office by 03.30 P.M. on Wednesday, December 05, 2018.

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at B & K’s Investor Conference- Emergent India- 2018 organized by M/s. Batlivala & Karani Securities India Pvt. Ltd., at Hotel Trident BKC, Mumbai, on Wednesday, 5th December 2018, where the representatives of various Funds would be meeting, from 10.00 A.M to 6.00 P.M.

Intimation that Mr. Navin Ramachandran, Fund Manager and Mr. V. Srinath, Senior Analyst of Bellwether Capital would be having a meeting with Mr. Sachin Salvi, General Manager-Finance, at our office by 02.30 P.M. on Wednesday, November 28, 2018.

Intimation that Mr. Anand Velumani, Director of our wholly owned subsidiary, Nueclear Healthcare Limited, and Mr. Aditya Shinde, Deputy General Manager- Finance would be participating at Annual C.H.A.M.P.S. Conference organized by M/s. Spark Capital Advisors (India) Private Limited, at Hotel Trident BKC, Mumbai, on Friday, 16th November 2018, where they would be meeting representatives of various Funds, between 10.00 A.M. and 2.00

Post-script of the conference call of Indian and Overseas Investors held on 12-11-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter /half year ended 30-09-2018.View Here

Intimation that Mr. Sachin Salvi, General Manager-Finance, would be participating at IDFC Securities Annual Investor Conference ‘The Stock called India’ organized by M/s. IDFC Securities Limited, at Hotel Grand Hyatt, Mumbai, on Wednesday, 21st November 2018, where he would be meeting various investors between 2.00 P.M and 6.00 P.M.

Intimation about conference call for Indian and Overseas Investors to be held on 12-11-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter / half year ended 30-09-2018.Click to see invite Here

Intimation about the outcome of the Board Meeting held on 03-11-2018 – Approval of unaudited financial results for the quarter/half year ended 30-09-2018 and approval of issue & allotment of 33,973 equity shares to eligible employees who have exercised the Options granted to them in 2015.

Intimation that Mr. Suney Hindocha and Mr. Edward Lam, Fund Managers of Somerset Capital Management, UK, would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 22, 2018.

Intimation that Mr. Stephen Farley, Managing Partner and Mr. Andrei Stetsenko, Partner of Farley Capital, New York would be having a meeting with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Anand Velumani, Director of our subsidiary company, Nueclear Healthcare Ltd., at our office by 9.30 A.M. on Thursday, November 15, 2018.

Intimation about Board Meeting scheduled to be held on November 03, 2018, to inter alia, consider and approve the unaudited financial results (both Stand-alone and Consolidated) for the quarter / half year ended 30th September 2018.

Intimation about closure of Trading Window for Directors, Employees and Connected Persons from October 25, 2018 to November 06, 2018 (both days inclusive).

Intimation that Mr. Krishnakumar, CIO of Sundaram Mutual Fund would be having a con-call with our Chairman & Managing Director, Dr. A. Velumani on Friday, October 05, 2018, by 10.00 A.M.

Intimation about meeting of Mr. Sunil Asnani, Portfolio Manager, of Matthews International Capital Management, with one or more of the following, viz. Mr. Anand Velumani, Dr. Caesar Sengupta, Vice President-Operations, Mr. Sachin Salvi, General Manager-Finance, and Mr. Vatsal Goyal, Head-Strategy & Corporate Development, at our office by 04.00 P.M. on Monday, September 10, 2018.

Intimation about participation of Mr.Anand Velumani, and Mr. Aditya Shinde, Deputy General Manager-Finance in the Investor Conference organised by Motilal Oswal Securities Limited, at Hotel Grand Hyatt on Tuesday and Wednesday, August 28 and 29, 2018. View here

Intimation about meeting of Mr. Kalpraj Dharamshi, Promoter of Dharamshi Securities Private Limited & Valuequest Investment Advisors P.Ltd., with our Chairman, Managing Director and CEO, Dr. A. Velumani, at our office by 11.30 A.M. on Friday, September 07, 2018.

Intimation that Mr. Masahiro Kanezaki , Portfolio Manager of Portfolia Japan, who would meet our Chairman, Managing Director & CEO, Dr.A. Velumani on 06-09-2018, is a client of Kim Eng Securities India P. Ltd., and not part of Maybank, as earlier reported by us.

Intimation about meeting of Mr. Apurv Kulkarni, Senior Analyst of Nine Rivers Capital Holdings Pvt. Ltd., with Dr. Caesar Sengupta, Vice-President-Operations, Mr. Sachin Salvi, General Manager-Finance and Mr. Vatsal Goyal, Head- Strategy and Corporate Development, at our office by 2.00 P.M. on Tuesday, August 28, 2018.

Post-script of the conference call of Indian and Overseas Investors held on 14-08-2018 to discuss about unaudited financial results (stand-alone & consolidated) for the quarter ended 30-06-2018. View Here

Intimation about meeting of Mr. A. N. Seshadri, Principal and Mr. Gaurav Kothari, Fund Manager of Nalanda Capital, with our Chairman, Managing Director & CEO, Dr. A. Velumani and other key managerial personnel, at our office from 2.30 P.M. on Tuesday, August 21, 2018.

Intimation about meeting of Mr. Masahiro Kanezaki, Portfolio Manager of Portfolia Japan, a part of Maybank, Malaysia, with our Chairman, Managing Director & CEO, Dr. A. Velumani, at our office by 9.30 A.M. on Thursday, September 06, 2018.

Intimation about conference call of Indian and Overseas Investors to be held on 14-08-2018 to discuss about Unaudited financial results (Stand-alone and Consolidated) for the quarter ended 30-06-2018.